{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:00:27Z","timestamp":1788537627489,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/bjc.2012.590","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T23:55:17Z","timestamp":1357257317000},"page":"676-680","source":"Crossref","is-referenced-by-count":23,"title":["Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer"],"prefix":"10.1038","volume":"108","author":[{"given":"C P H","family":"Vreuls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W M","family":"Olde Damink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G H","family":"Koek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H E","family":"Cloots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A J","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H C","family":"Dejong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F T","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"BFbjc2012590_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/bjs.5764","volume":"94","author":"R Adam","year":"2007","unstructured":"Adam R (2007) Colorectal cancer with synchronous liver metastases. Br J Surg 94: 129\u2013131","journal-title":"Br J Surg"},{"key":"BFbjc2012590_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/01.sla.0000145964.08365.01","volume":"240","author":"R Adam","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644\u2013657; discussion 657\u2013658","journal-title":"Ann Surg"},{"key":"BFbjc2012590_CR3","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1200\/JCO.2005.07.740","volume":"23","author":"SR Alberts","year":"2005","unstructured":"Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23: 9243\u20139249","journal-title":"J Clin Oncol"},{"key":"BFbjc2012590_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759\u2013766","journal-title":"Ann Surg"},{"key":"BFbjc2012590_CR5","first-page":"1261","volume":"268","author":"LD Deleve","year":"1994","unstructured":"Deleve LD (1994) Dacarbazine toxicity in murine liver cells: a model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 268: 1261\u20131270","journal-title":"J Pharmacol Exp Ther"},{"key":"BFbjc2012590_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, Kanel GC (1999) Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 29: 1779\u20131791","journal-title":"Hepatology"},{"key":"BFbjc2012590_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/17425250903427980","volume":"6","author":"G Di Pietro","year":"2010","unstructured":"Di Pietro G, Magno LA, Rios-Santos F (2010) Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 6: 153\u2013170","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"BFbjc2012590_CR8","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1001\/jama.299.20.2423","volume":"299","author":"LM Dong","year":"2008","unstructured":"Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299: 2423\u20132436","journal-title":"JAMA"},{"key":"BFbjc2012590_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/01.sla.0000138076.72547.b1","volume":"240","author":"FG Fernandez","year":"2004","unstructured":"Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438\u2013447; discussion 447\u2013450","journal-title":"Ann Surg"},{"key":"BFbjc2012590_CR10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00535-009-0124-9","volume":"44","author":"T Furuta","year":"2009","unstructured":"Furuta T (2009) Pharmacogenomics in chemotherapy for GI tract cancer. J Gastroenterol 44: 1016\u20131025","journal-title":"J Gastroenterol"},{"key":"BFbjc2012590_CR11","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1038\/sj.bjc.6601843","volume":"90","author":"JE Husband","year":"2004","unstructured":"Husband JE, Schwartz LH, Spencer J, Ollivier L, King DM, Johnson R, Reznek R (2004) Evaluation of the response to treatment of solid tumours \u2013 a consensus statement of the International Cancer Imaging Society. Br J Cancer 90: 2256\u20132260","journal-title":"Br J Cancer"},{"key":"BFbjc2012590_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/annonc\/mdj063","volume":"17","author":"A Jatoi","year":"2006","unstructured":"Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM (2006) Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol 17: 29\u201334","journal-title":"Ann Oncol"},{"issue":"2","key":"BFbjc2012590_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61 (2): 69\u201390","journal-title":"CA Cancer J Clin"},{"key":"BFbjc2012590_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 44: 778\u2013783","journal-title":"Transplantation"},{"key":"BFbjc2012590_CR15","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1200\/JCO.2005.05.112","volume":"23","author":"FF Kabbinavar","year":"2005","unstructured":"Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, Mass R, Perrou B, Nelson B, Novotny WF (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23: 3697\u20133705","journal-title":"J Clin Oncol"},{"key":"BFbjc2012590_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","volume":"31","author":"DM Kweekel","year":"2005","unstructured":"Kweekel DM, Gelderblom H, Guchelaar HJ (2005) Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy. Cancer Treat Rev 31: 90\u2013105","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2012590_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/SLA.0b013e3182356236","volume":"255","author":"K Lehmann","year":"2012","unstructured":"Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA (2012) Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 255: 237\u2013247","journal-title":"Ann Surg"},{"key":"BFbjc2012590_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","volume":"247","author":"H Nakano","year":"2008","unstructured":"Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247: 118\u2013124","journal-title":"Ann Surg"},{"key":"BFbjc2012590_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33: 9\u201323","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2012590_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cld.2010.07.009","volume":"14","author":"L Rubbia-Brandt","year":"2010","unstructured":"Rubbia-Brandt L (2010) Sinusoidal obstruction syndrome. Clin Liver Dis 14: 651\u2013668","journal-title":"Clin Liver Dis"},{"key":"BFbjc2012590_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460\u2013466","journal-title":"Ann Oncol"},{"key":"BFbjc2012590_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S, Mentha G, Terris B (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18: 299\u2013304","journal-title":"Ann Oncol"},{"key":"BFbjc2012590_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","volume":"56","author":"L Rubbia-Brandt","year":"2010","unstructured":"Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56: 430\u2013439","journal-title":"Histopathology"},{"key":"BFbjc2012590_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","volume":"10","author":"L Rubbia-Brandt","year":"2011","unstructured":"Rubbia-Brandt L, Tauzin S, Brezault C, Delucinge-Vivier C, Descombes P, Dousset B, Majno PE, Mentha G, Terris B (2011) Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans. Mol Cancer Ther 10: 687\u2013696","journal-title":"Mol Cancer Ther"},{"key":"BFbjc2012590_CR25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","volume":"104","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M, Krishnamoorthy R (2004) Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 104: 1574\u20131577","journal-title":"Blood"},{"key":"BFbjc2012590_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","volume":"18","author":"D Tamandl","year":"2011","unstructured":"Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T (2011) Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 18: 421\u2013430","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2012590_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/hep.510310224","volume":"31","author":"X Wang","year":"2000","unstructured":"Wang X, Kanel GC, DeLeve LD (2000) Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 31: 428\u2013434","journal-title":"Hepatology"},{"key":"BFbjc2012590_CR28","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1200\/JCO.2008.16.1893","volume":"26","author":"J Ward","year":"2008","unstructured":"Ward J, Guthrie JA, Sheridan MB, Boyes S, Smith JT, Wilson D, Wyatt JI, Treanor D, Robinson PJ (2008) Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 26: 4304\u20134310","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012590","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:12:50Z","timestamp":1684415570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFbjc2012590"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.590","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}